Paradigm Research   Report issue

For profit Phase 2
Founded: Redding CA United States (2009)

Organization Overview

First Clinical Trial
2016
NCT02831751
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Paradigm Research, Redding (CA), USA

Active Ingredients

Drugs in Phase 2 Trials (3)

flulaval (1 trial)

inactivated influenza vaccine (1 trial)

influenza vlp vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Influenza, Human (Phase 2)

Respiratory Tract Diseases (Phase 2)

Respiratory Tract Infections (Phase 2)

RNA Virus Infections (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3